A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer

Elevated expression of the chemokine receptor CCR4 in tumors is associated with poor prognosis in several cancers. Here, we have determined that CCR4 was highly expressed in human renal cell carcinoma (RCC) biopsies and observed abnormal levels of CCR4 ligands in RCC patient plasma. An antagonistic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Invest
Glavni autori: Berlato, Chiara, Khan, Moddasar N., Schioppa, Tiziana, Thompson, Richard, Maniati, Eleni, Montfort, Anne, Jangani, Maryam, Canosa, Monica, Kulbe, Hagen, Hagemann, Urs B., Duncan, Alexander R., Fletcher, Laura, Wilkinson, Robert W., Powles, Thomas, Quezada, Sergio A., Balkwill, Frances R.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Clinical Investigation 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330727/
https://ncbi.nlm.nih.gov/pubmed/28134623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI82976
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items